Rabeprazole sodium enteric-coated tablets are generally not clinically recommended for long-term use. Rabeprazole sodium enteric coated tablets is a proton pump inhibitor, which is mainly applied to gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux esophagitis and other diseases, and can also be used for the treatment of Helicobacter pylori. Drug allergy is prohibited. Usually clinically, rabeprazole sodium enteric-coated tablets can not be taken for a long time, long-term large amounts may cause dyspepsia, benign gastric polyps, atrophic gastritis and other pathologic conditions, but also may cause impaired liver function and blood cell abnormalities, resulting in pharmacological damage. It is recommended that patients take the drug under the guidance of the doctor according to the course of treatment, not without authorization, so as not to cause adverse effects.